NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis.
about
Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patientsPharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysisInfluence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)Antituberculosis drug-induced hepatotoxicity in childrenNAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis.Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients.A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism.Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs.Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis.Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis.Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis.Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients.
P2860
Q28478275-679AD0C1-DF5B-403C-9BE6-6CD4219E055DQ28484468-C134ED84-C046-4FFF-A805-CC06380DC383Q33901424-1AB40D1C-62CB-4757-920C-A0F0FBE9A49DQ35096954-C5342125-A037-4141-9C9D-2D6D787103B9Q35934555-16C89B82-63F5-41C7-A2B5-95C9A39F672CQ37030180-27F2756C-8B1A-4B09-AE13-E46A41CE7609Q37131701-8787002E-947E-42BE-A8E0-2C642773BE17Q37268068-8965A90D-2913-406F-86CA-DA1761F2F3ACQ40480835-267B5934-41B9-4E49-8DA4-B98F1879ED80Q41901707-F8553B93-DF18-44D2-93FD-CD4BFE590F42Q42284821-1EC658F3-B135-46CE-932D-978DF48CC92CQ42696912-E27CEB3C-D089-4AFB-96F8-F89F2BEBE423Q43248041-7A1865BE-F35C-43A2-A62D-0FE814838E03Q43474583-928F4039-3E80-4DD6-83BB-534B7AC1426AQ45344839-BD56DBD0-A316-4136-9A8B-B23642B7B545Q45766101-B7D10C6B-73F0-4D98-A074-DED296DE748DQ51569750-4D458358-F098-4C11-BF6A-F2AA42DF855BQ53765768-76619876-2BBE-4FE9-95F2-5847E9A6D6B8Q54314510-3B21D075-1101-4614-AF90-8EF602699FB9
P2860
NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@ast
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@en
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@nl
type
label
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@ast
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@en
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@nl
prefLabel
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@ast
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@en
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@nl
P2093
P2860
P921
P356
P1476
NAT2 6A, a haplotype of the N- ...... se patients with tuberculosis.
@en
P2093
Chun-Yang Wen
Hajime Isomoto
Katsuhisa Omagari
Katsunori Yanagihara
Kazuhiro Tsukamoto
Kiyoyasu Fukushima
Kohichiro Yoshiura
Naofumi Suyama
Naoko Tahara
Norihide Higuchi
P2860
P304
P356
10.3748/WJG.13.6003
P407
P577
2007-12-01T00:00:00Z